UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

High glucose promotes regulatory T cell differentiation

PloS one, 2023-02, Vol.18 (2), p.e0280916-e0280916

2023

Volltextzugriff (PDF)

IL-17 inhibits CXCL9/10-mediated recruitment of CD8+ cytotoxic T cells and regulatory T cells to colorectal tumors

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.324-324, Article 324

2019

Volltextzugriff (PDF)

Letter from the Editor and Introduction to the 2023 Thematic Issue

Immunological investigations, 2024, Vol.53 (1), p.1-5

Adler, Adam J

2024

Volltextzugriff (PDF)

Macrophage polarization and meta-inflammation

Translational research : the journal of laboratory and clinical medicine, 2018-01, Vol.191, p.29-44

2018

Volltextzugriff (PDF)

Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism

Cell reports (Cambridge), 2019-04, Vol.27 (5), p.1434-1445.e3

2019

Volltextzugriff (PDF)

Cancer Immunology and Immunotherapy: From Defining Basic Immunology to Leading the Fight Against Cancer

Immunological investigations, 2022-11, Vol.51 (8), p.2128-2132

Adler, Adam J.

2022

Volltextzugriff (PDF)

Letter from the Editor: 2022

Immunological investigations, 2022-11, Vol.51 (8), p.2123-2127

Adler, Adam J.

2022

Volltextzugriff (PDF)

Letter from the Editor: 2021

Immunological investigations, 2021-10, Vol.50 (7), p.735-739

Adler, Adam J.

2021

Volltextzugriff (PDF)

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (26), p.10486-10491

2012

Volltextzugriff (PDF)

Addressing current challenges in cancer immunotherapy with mathematical and computational modelling

Journal of the Royal Society interface, 2017-06, Vol.14 (131)

2017

Volltextzugriff (PDF)

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells

Blood, 2012-12, Vol.120 (24), p.4772-4782

2012

Volltextzugriff (PDF)

Lymphocyte Activation Gene-3 Regulates Dendritic Cell Metabolic Programing and T Cell Priming Function

The Journal of immunology (1950), 2021-11, Vol.207 (9), p.2374-2384

2021

Volltextzugriff (PDF)

A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors

Scientific reports, 2019-07, Vol.9 (1), p.10862-12, Article 10862

2019

Volltextzugriff (PDF)

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation

The Journal of immunology (1950), 2011-10, Vol.187 (7), p.3555-3564

2011

Volltextzugriff (PDF)

Dual Sovereignty, Due Process, and Duplicative Punishment: A New Solution to an Old Problem

The Yale law journal, 2014-11, Vol.124 (2), p.448-483

ADLER, ADAM J.

2014

Volltextzugriff (PDF)

GRK2 enforces androgen receptor dependence in the prostate and prostate tumors

Oncogene, 2020-03, Vol.39 (11), p.2424-2436

2020

Volltextzugriff (PDF)

Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity

The Journal of immunology (1950), 2009-12, Vol.183 (11), p.7161-7168

2009

Volltextzugriff (PDF)

The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death

Journal of leukocyte biology, 2009-01, Vol.85 (1), p.175-185

2009

Volltextzugriff (PDF)

Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis

The Journal of immunology (1950), 2016-01, Vol.196 (1), p.124-134

2016

Volltextzugriff (PDF)

An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells

The Journal of immunology (1950), 2018-02, Vol.200 (4), p.1513-1526

2018

Volltextzugriff (PDF)

Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?

Expert opinion on biological therapy, 2016-05, Vol.16 (5), p.655-674

2016

Volltextzugriff (PDF)

Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy

The Journal of immunology (1950), 2015-12, Vol.195 (12), p.5816-5826

2015

Volltextzugriff (PDF)

Cutting Edge: Paracrine, but Not Autocrine, IL-2 Signaling Is Sustained during Early Antiviral CD4 T Cell Response

The Journal of immunology (1950), 2006-10, Vol.177 (7), p.4257-4261

2006

Volltextzugriff (PDF)

A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice

Cancer Immunology, Immunotherapy, 2018-04, Vol.67 (4), p.605-613

2018

Volltextzugriff (PDF)

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

Cancer cell, 2005-03, Vol.7 (3), p.239-249

2005

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(238)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(157)
Humans
(114)
Animals
(66)
Female
(53)
Mice
(51)
Male
(48)
Immunology
(39)
Biological And Medical Sciences
(32)
Middle Aged
(28)
Medical Sciences
(25)
Adult
(23)
Cd4-Positive T-Lymphocytes - Immunology
(21)
Mice, Transgenic
(19)
Aged
(18)
Oncology
(17)
Science & Technology - Other Topics
(16)
Medicin Och Hälsovetenskap
(15)
Multidisciplinary Sciences
(14)
Cancer
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

High glucose promotes regulatory T cell differentiation

IL-17 inhibits CXCL9/10-mediated recruitment of CD8+ cytotoxic T cells and regulatory T cells to colorectal tumors

Letter from the Editor and Introduction to the 2023 Thematic Issue

Macrophage polarization and meta-inflammation

Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism

Cancer Immunology and Immunotherapy: From Defining Basic Immunology to Leading the Fight Against Cancer

Letter from the Editor: 2022

Letter from the Editor: 2021

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness

Addressing current challenges in cancer immunotherapy with mathematical and computational modelling

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells

Lymphocyte Activation Gene-3 Regulates Dendritic Cell Metabolic Programing and T Cell Priming Function

A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation

Dual Sovereignty, Due Process, and Duplicative Punishment: A New Solution to an Old Problem

GRK2 enforces androgen receptor dependence in the prostate and prostate tumors

Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity

The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death

Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis

An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells

Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?

Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy

Cutting Edge: Paracrine, but Not Autocrine, IL-2 Signaling Is Sustained during Early Antiviral CD4 T Cell Response

A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

Suchergebnisse filtern